Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial - Ranjbar, Keivan; Moghadami, Mohsen; Mirahmadizadeh, Alireza; Fallahi, Mohammad Javad; Khaloo, Vahid; Shahriarirad, Reza; Erfani, Amirhossein; Khodamoradi, Zohre; Gholampoor Saadi, Mohammad Hasan (BMC infectious diseases, 2021)
Keywords: Adrenal Cortex Hormones - therapeutic use; Adult; Aged; Blood pressure; Clinical trials; Comparative analysis; Coronaviruses; Corticosteroid; Corticosteroids; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Dexamethasone - therapeutic use; Diabetes; Disease; Drug therapy; Enrollments; Female; Health services; Hospital patients; Hospitalization; Hospitals; Humans; Hypoxia; Infectious diseases; Intervention; Iran; Length of Stay; Male; Methylprednisolone; Methylprednisolone - therapeutic use; Middle Aged; Middle East respiratory syndrome; Mortality; Pathogenesis; Patients; Prospective Studies; Randomized controlled trial; Respiration, Artificial; Respiratory diseases; Severe acute respiratory syndrome coronavirus 2; Steroids; Testing; Treatment Outcome; Vaccines; Viral diseases; Iran; COVID-19; Corticosteroid; Dexamethasone; Methylprednisolone; Randomized controlled trial